Login
From:
Cassava Sciences, Inc.
(Uncensored)
subscribe
Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease | Cassava Sciences, Inc.
https://www.cassavasciences.com/news-releases/news-release-details/cassava-sciences-announces-positive-interim-safety-review
links
backlinks
Roast topics
Find topics
Find it!
The Investor Relations website contains information about Cassava Sciences, Inc.'s business for stockholders, potential investors, and financial analysts.
